Related Experiment Video
Updated: Aug 30, 2026

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
Published on: August 19, 2021
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a
Keith G Rosauer1, Anthony K Ogawa, Chris A Willoughby
1Department of Basic Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. keith_rosauer@merck.com
Abstract:
The preparation of a series of substituted indoles coupled to six- and seven-membered cyclic lactams is described and their role as human glycogen phosphorylase a inhibitors discussed. The SAR of the indole moiety and lactam ring are presented.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Oral Hypoglycemic Agents: Glinides
Antiviral Nucleoside Inhibitors
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Inhibitors of Bacterial DNA Synthesis